Significance of image analysis in the diagnosis of bone tumors and tumor-like lesions

The distinction between different types of giant-cell containing lesions often represents a challenge for pathologists since wide ranges and overlappings of their morphological features are common. But despite of their similarities the treatment is very different and depends on an accurate morpological diagnostic. Our present study was undertaken to investigate the nuclear DNA content (NDC) of giant-cell containing lesions and its value for the diagnostic. Furthermore we studied the significance of NDC to predict the biological behavior of giant-cell tumors. 12 aneurysmal bone cysts 25 central osteosarcomas (biopsies) and 16 giant-cell tumors of the Hamburger Knochentumorregister were included in this study. In all cases fresh material was available. 20 imprintcytologies from each specimen of each case were prepared . 10 were used for Feulgen-staining to perform quantitative DNA-measurements. 10 were used for Pappenheim-staining for morphological examination. Conventionally prepared sections of each specimen of each patient radiological findings and clinical data served as control-system. The recently developed DNA measuring program CESAR based on image analysis (IBAS I Kontron Germany) was used for this study. The obtained DNA distributions were classified according to a new developed DNAgrading system for imprintcytologies (s. table 1). All investigated aneurysmal bone cysts were 0 I (euploid). 23 central osteosarcomas were G III (aneuploid). 2 central osteosarcomas (predominantly cartilage producing) were G II (only a small number of hypertetraploid cells). 9 giant-cell tumors were G II. 7 Giant

[1]  W. Enneking,et al.  Giant-cell tumor of bone with pulmonary metastases. , 1985, The Journal of bone and joint surgery. American volume.

[2]  C. Duncan,et al.  Giant cell tumour of bone: its aggressiveness and potential for malignant change. , 1983, Canadian journal of surgery. Journal canadien de chirurgie.

[3]  L. Koss,et al.  The diagnostic value of flow cytometric DNA measurements in follicular tumors of the thyroid gland , 1985, Cancer.

[4]  H. Joensuu,et al.  Influence of cellular DNA content on survival in differentiated thyroid cancer , 1986, Cancer.

[5]  J. Smith,et al.  Giant-cell tumor of the sacrum. Clinical and radiologic features in 13 patients. , 1979, Journal of the Canadian Association of Radiologists.

[6]  D. Jocham,et al.  DNA-grading of prostatic carcinoma: prognostic validity and reproducibility. , 1988, Anticancer research.

[7]  U. Abel,et al.  Correlation of dna flow cytometric results and other prognostic factors in primary breast cancer , 1988, International journal of cancer.

[8]  M. Rock,et al.  Metastases from histologically benign giant-cell tumor of bone. , 1984, The Journal of bone and joint surgery. American volume.

[9]  B. Tribukait,et al.  DNA flow analysis of soft tissue tumors , 1987, Cancer.

[10]  M. Ladanyi,et al.  Benign metastasizing giant cell tumors of bone. A DNA flow cytometric study , 1989, Cancer.

[11]  C. Silfverswärd,et al.  DNA analysis in the differential diagnosis of osteosarcoma , 1988, Cancer.

[12]  W. Auffermann,et al.  DNA-grading of malignant lymphomas. I. Prognostic significance, reproducibility and comparison with other classifications. , 1986, Anticancer research.

[13]  M. Sobrinho-Simões,et al.  The diagnostic value of flow cytometric DNA measurements in selected disorders of the human thyroid. , 1982, American journal of clinical pathology.

[14]  D. Dahlin Caldwell Lecture. Giant cell tumor of bone: highlights of 407 cases. , 1985, AJR. American journal of roentgenology.

[15]  A. Rydholm,et al.  Aspiration of musculoskeletal tumors for cytodiagnosis and DNA analysis. , 1987, Acta orthopaedica Scandinavica.

[16]  R. Cowan,et al.  Prognostic relevance of DNA content in childhood renal tumours. , 1989, British Journal of Cancer.

[17]  W. Auffermann,et al.  Algorithm for a DNA-cytophotometric diagnosis and grading of malignancy. , 1984, Analytical and quantitative cytology.

[18]  O. Kallioniemi,et al.  DNA flow cytometric analysis indicates that many breast cancers detected in the first round of mammographic screening have a low malignant potential , 1988, International journal of cancer.

[19]  M. Bronner,et al.  Flow cytometric analysis of DNA content in Hürthle cell adenomas and carcinomas of the thyroid. , 1988, American journal of clinical pathology.

[20]  Morton Ks,et al.  Giant cell tumour of bone: its aggressiveness and potential for malignant change. , 1983 .

[21]  R. Rossner,et al.  DNA-grading of malignant lymphomas. II. Correlation with clinical parameters. , 1986, Anticancer research.

[22]  M. Bäckdahl,et al.  Ploidy levels in nonneoplastic and neoplastic thyroid cells. , 1985, Analytical and quantitative cytology and histology.

[23]  K. Christov Flow cytometric DNA measurements in human thyroid tumors , 1986, Virchows Archiv. B, Cell pathology including molecular pathology.

[24]  H. Joensuu,et al.  Clinical significance of abnormal nuclear DNA content in serous ovarian tumors , 1988, Cancer.